Related Experiment Videos
MicroRNAs: Role in Hepatitis C Virus pathogenesis
Shubham Shrivastava1, Robert Steele1, Ranjit Ray2
1Departments of Pathology, Saint Louis University, St. Louis, Missouri, USA.
Insights
Hepatitis C virus (HCV) infection involves microRNAs (miRNAs) that regulate host factors and disease progression. Circulating miRNAs show potential as biomarkers for early diagnosis and therapeutic intervention in liver disease.
Area of Science:
- Hepatology
- Virology
- Molecular Biology
Background:
- Hepatitis C virus (HCV) affects millions globally, leading to severe liver conditions like cirrhosis and cancer.
- Direct-acting antiviral (DAA) drugs offer high cure rates, but long-term outcomes require further study.
- MicroRNAs (miRNAs) are critical in HCV infection, influencing host factors essential for viral replication and cell growth.
Purpose of the Study:
- To review the role of miRNAs in the HCV life cycle.
- To explore the coordinated regulation of miRNAs in HCV-mediated liver disease progression.
- To highlight the potential of circulating miRNAs as diagnostic and prognostic biomarkers.
Main Methods:
- Literature review of recent studies on miRNAs and HCV.
- Analysis of miRNA involvement in host-pathogen interactions.
- Examination of miRNA regulatory networks in HCV pathogenesis.
Main Results:
- Altered miRNA expression is implicated in HCV pathogenesis by controlling immune response, proliferation, and apoptosis.
- miRNAs act as intercellular communicators within the liver during HCV infection.
- miRNAs are crucial for HCV replication and host cell modulation.
Conclusions:
- miRNAs play a significant role in HCV infection and the progression of liver disease.
- Circulating miRNAs may serve as valuable biomarkers for disease progression and early therapeutic intervention in end-stage liver disease.
- Further research into miRNA function can lead to novel diagnostic and therapeutic strategies for HCV.
Abstract:
Hepatitis C virus (HCV) is a global health burden with an estimated 170-200 million peoples chronically infected worldwide. HCV infection remains as an independent risk factor for chronic hepatitis, liver cirrhosis, hepatocellular carcinoma, and a major reason for liver transplantation. Discovery of direct acting antiviral (DAA) drugs have shown promising results with more than 90% success rate in clearing the HCV RNA in patients, although long-term consequences remain to be evaluated. microRNAs (miRNAs) are important players in establishment of HCV infection and target crucial host cellular factors needed for productive HCV replication and augmented cell growth. Altered expression of miRNAs is involved in the pathogenesis associated with HCV infection by controlling signaling pathways such as immune response, proliferation and apoptosis. miRNA is emerging as a means of communication between various cell types inside the liver. There is likely possibility of developing circulating miRNAs as biomarkers of disease progression and can also serve as diagnostic tool with potential of early therapeutic intervention in HCV associated end stage liver disease. This review focuses on recent studies highlighting the contribution of miRNAs in HCV life cycle and their coordinated regulation in HCV mediated liver disease progression.
Related Concept Videos
Viruses with RNA Genomes
MicroRNAs
MicroRNAs
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Mechanisms of Retrovirus-induced Cancers
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...